Abilify and Breast lump - a phase IV clinical study of FDA data

Summary:

Breast lump is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Risperdal, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Breast lump when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.

What is Breast lump?

Breast lump (localized swelling that feels different from the surrounding breast tissue) is found to be associated with 797 drugs and 921 conditions by eHealthMe. Check the latest studies of Breast lump.

On Apr, 19, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 45 people (0.05%) have Breast lump.

Among these 45 people:

How long have people been on Abilify when they have Breast lump? *

What is the gender of people who have Breast lump when taking Abilify? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Breast lump when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Breast lump? *

Weight Increased: 12 people, 26.67%
Gynecomastia (enlargement of the gland tissue of the male breast): 12 people, 26.67%
Breast Discharge: 9 people, 20.00%
High Blood Pressure: 8 people, 17.78%
Suicidal Ideation: 7 people, 15.56%
Fatigue (feeling of tiredness): 7 people, 15.56%
Rashes (redness): 7 people, 15.56%
Stress And Anxiety: 7 people, 15.56%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 15.56%
Back Pain: 7 people, 15.56%

What are the existing conditions these people have? *

Stress And Anxiety: 14 people, 31.11%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 7 people, 15.56%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 5 people, 11.11%
Pain: 5 people, 11.11%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 4 people, 8.89%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 6.67%
Psychotic Disorder: 3 people, 6.67%
Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 3 people, 6.67%
Insomnia (sleeplessness): 2 people, 4.44%
Drug Hypersensitivity: 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Breast lump?

- Check whether Breast lump is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,450 reports)

Breast lump treatments and more:

Breast lump (9,236 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast lump:

Breast lump (797 drugs)

Browse all the conditions that are associated with Breast lump:

Breast lump (921 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.